首页> 外文OA文献 >Assessing the impact of subsequent checkpoint inhibitor (CPI) treatment on overall survival: Post hoc analyses from the phase III JAVELIN Lung 200 study of avelumab vs docetaxel in platinum-treated locally advanced/metastatic non-small cell lung cancer (NSCLC)

【2h】

Assessing the impact of subsequent checkpoint inhibitor (CPI) treatment on overall survival: Post hoc analyses from the phase III JAVELIN Lung 200 study of avelumab vs docetaxel in platinum-treated locally advanced/metastatic non-small cell lung cancer (NSCLC)

机译：评估随后的检查点抑制剂（CPI）治疗总体存活的影响：从铂治疗的局部晚期/转移性非小细胞肺癌（NSCLC）中Avelumab vs多西紫杉醇的III型Javelin肺200研究。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F. Barlesi; M. Özgüroğlu; J.F. Vansteenkiste; D. Spigel; J C-H Yang; M. Bajars; M. Ruisi; J. Manitz; K. Park;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study [J] . Barlesi Fabrice, Vansteenkiste Johan, Spigel David, The lancet oncology . 2018,第11期

机译：Avelumab对多西紫杉醇的铂治疗的晚期非小细胞肺癌（Javelin Lung 200）：开放标签，随机，第3期研究
2. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study (vol 19, pg 1468, 2018) [J] . Barlesi F., Vansteenkiste J., Spigel D. The lancet oncology . 2018,第11期

机译：Avelumab与多西紫杉醇患者铂治疗的先进非小细胞肺癌（Javelin Lung 200）：开放标签，随机，第3阶段研究（Vol 19，PG 1468,2018）
3. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [J] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, Drugs in R&D . 2013,第4期

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
4. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
5. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, -1

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
6. Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial [O] . Keunchil Park, Mustafa Özgüroğlu, Johan Vansteenkiste, 2021

机译：随后的免疫检查点抑制剂治疗对铂治疗高级NSCLC中Avelumab Vs Docetaxel的整体存活的影响：从第3阶段3枪肺200次试验中分析

Assessing the impact of subsequent checkpoint inhibitor (CPI) treatment on overall survival: Post hoc analyses from the phase III JAVELIN Lung 200 study of avelumab vs docetaxel in platinum-treated locally advanced/metastatic non-small cell lung cancer (NSCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅